Understanding LGBTQ+ Patients’ Needs in Cancer Care

Cancer care should be safe, clinically effective and respectful for every person. LGBTQ+ patients may face the same diagnosis and treatment decisions as other patients, yet their experience can be shaped by identity, past discrimination, family relationships, financial pressures and concerns about being misgendered or judged.

Sexual orientation, gender identity and variations in sex characteristics are not themselves illnesses. They are relevant to care when they affect screening history, anatomy, medication, fertility, mental health, support networks or a patient’s willingness to disclose important information. Good practice means asking what matters to the individual rather than relying on assumptions.

In Australia, cancer services operate across major metropolitan hospitals, regional centres, private clinics and Aboriginal Community Controlled Health Services. A patient from Brisbane may move between the Royal Brisbane and Women’s Hospital, a local GP, a regional radiotherapy service and community organisations. Consistent, inclusive communication across those settings can make treatment easier to navigate.

Research translation has a practical role in this work. The Brisbane Diamantina network connects researchers, universities and health services so evidence can inform clinical practice, workforce education and better outcomes for patients, families and carers.

Creating A Safe First Conversation

The first appointment can determine whether a patient feels able to speak openly. Staff should use the person’s stated name and pronouns, avoid gendered assumptions and explain why particular questions are clinically relevant. A simple statement such as “We ask these questions of everyone so we can provide appropriate care” can make demographic and sexual health forms feel less intrusive.

Intake systems should allow patients to record a preferred name, pronouns, gender identity, sexual orientation and emergency contact details. These fields need to flow accurately through electronic medical records, correspondence and referrals. Privacy matters, especially when a legal name appears on Medicare records or when a patient is not out to every family member.

Staff should also recognise that disclosure is voluntary. A patient may have experienced rejection, conversion practices, violence, poor healthcare or breaches of confidentiality. Trust develops through consistent behaviour, not a single diversity statement on a clinic wall.

Understanding Different Cancer Risks

Cancer prevention and screening advice should be based on relevant anatomy, age, personal history and risk factors. Trans men and some non-binary people may still need cervical screening if they have a cervix, while trans women may need individualised breast or prostate health advice. Screening conversations should avoid suggesting that gender identity determines a person’s organs or risks.

LGBTQ+ people are diverse, and evidence is still incomplete for some groups. Sexual minority women may have different patterns of screening participation, while some gay and bisexual men may have concerns relating to anal health, HIV or stigma. Intersex people can have specific anatomical and hormonal histories that require careful, individualised assessment.

Clinicians should explain uncertainty honestly and avoid presenting limited research as definitive. Recording relevant history, including previous surgeries, hormone therapy, HIV treatment or fertility preservation, supports safer decisions without reducing the patient to an identity label.

Supporting Patients Through Treatment

Chemotherapy, radiation, surgery and immunotherapy can affect body image, sexuality, sexual function, fertility and gender affirmation. A patient who has worked hard to feel comfortable in their body may experience hair loss, breast changes, scarring, weight change or hormonal disruption in especially complex ways.

Cancer teams should raise these issues early and offer referrals to fertility specialists, sexual health clinicians, psychologists, physiotherapists and peer support. Discussions should include practical concerns such as chest surgery, genital surgery, hormone therapy, contraception and whether treatment could alter hormone levels or interact with existing medicines.

Treatment plans also need to account for everyday realities. An LGBTQ+ patient may rely on a partner, chosen family or trusted friend rather than relatives. In Queensland, long travel from regional areas to Brisbane can make repeated appointments expensive and disruptive, so telehealth, transport assistance and coordinated appointments may be important parts of supportive care.

Respecting Partners, Families And Carers

A patient should decide who receives information and who participates in decisions, subject to consent and privacy requirements. A same-sex partner, trans partner, close friend or chosen family member may be the person providing transport, medication support and emotional care. Excluding that person because they are not a legal spouse can damage trust.

Forms, waiting-room language and visiting policies should reflect varied families. Staff can use “partner”, “support person” or “important person” rather than assuming a husband, wife, mother or father. Where a patient has children, clinicians should provide practical support for explaining cancer in age-appropriate language.

Aboriginal and Torres Strait Islander LGBTQ+ people may experience overlapping barriers involving racism, homophobia, transphobia, remoteness and mistrust of institutions. Culturally safe care requires listening to the individual, working with appropriate Aboriginal health services and avoiding a one-size-fits-all approach.

Improving Communication Across Services

Cancer journeys often involve GPs, pathology providers, surgeons, oncologists, pharmacists, allied health professionals and community services. A patient should not have to repeatedly correct pronouns, explain a chosen name or disclose sensitive history to every new clinician. Clear documentation and respectful handover reduce that burden.

Training should cover inclusive language, privacy, anatomy-based care, fertility, HIV, sexual health and the needs of trans and gender-diverse patients. It should be practical rather than symbolic, using local policies, case studies and opportunities to practise difficult conversations.

Queensland services can also work with LGBTIQ+ health organisations and consumer representatives to review forms, signage, websites and complaints pathways. Feedback should be welcomed without making patients responsible for educating the whole workforce.

Making Precision Care Equitable

Genomic testing and precision oncology may influence diagnosis, prognosis and treatment selection, but access and consent require careful attention. A patient may worry that genetic information could affect family relationships, insurance decisions or privacy. These concerns deserve a clear explanation before testing begins.

For patients with rare cancers or unusual clinical histories, ethical questions can be particularly complex. Guidance on precision medicine ethics can help teams consider consent, incidental findings, data sharing and the patient’s right to understand how samples and results will be used.

Inclusive care also means checking whether research recruitment is genuinely accessible. Eligibility criteria should not unnecessarily exclude people receiving gender-affirming hormones, living with HIV or using a chosen name. Researchers should collect identity data respectfully, protect confidentiality and report findings in ways that make LGBTQ+ communities visible without exposing individuals.

Measuring What Better Care Looks Like

Health services can monitor whether patients feel respected, understood and safe. Useful measures include correct use of names and pronouns, completion of relevant screening, access to fertility or sexual health advice, waiting times, complaints, treatment interruptions and patient-reported experience. Data should be collected transparently and interpreted with community input.

The following priorities can help a cancer service move from general commitment to practical action:

Services should involve LGBTQ+ consumers when designing policies and reviewing results. A small number of measurable changes—such as updating forms, improving referral language and establishing a clear escalation pathway—can be more meaningful than broad promises without accountability.

Every patient deserves cancer care that recognises the whole person, protects dignity and responds to individual clinical needs. Health services, researchers and community partners can strengthen this standard by embedding inclusive practice into screening, treatment, research and survivorship. Explore evidence-informed approaches, partnership opportunities and health translation work through Brisbane Diamantina Health Partners.